logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
C

Caigang Liu

China Medical University

35H指数
271论文数
4.0K被引数
收录论文 73
发表时间
logo
TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 studyTROP-2靶向抗体药物偶联物SHR-A1921治疗晚期或转移性实体瘤：一项首次人体1期研究
errCancer Cell
IF44.5
err2025-10-23
err0
PREAI
errJia Zhong; Lin Wu; Zhengbo Song; Nianzeng Xing; Jiujie Cui; Xingya Li; Kailun Fei; Dihong Tang; Qi Dang; Liang Chen; Tianshu Liu; Caigang Liu; Yong Li; Shichuan Zhang; Xinghua Han; Juxiang Xiao; Feng Guo; Min Yan; Huiting Xu; Chunxiu Yuan; Jincai Zhong; Rongrui Liu; Xiujuan Qu; Shikai Wu; Shusuan Jiang; Yan Yang; Panpan Zhang; Hongqian Guo; Ce Wang; Qiushi Xie; Zhifei Lin; Shuni Wang; Jie Wang
err分享
err收藏
CD8+ TILs in necrotic tumors after neoadjuvant immunochemotherapy predict outcomes in non-small-cell lung cancer patients坏死肿瘤中的CD8+ TILs在术前免疫化疗后可预测非小细胞肺癌患者的预后
errSignal Transduction and Targeted Therapy
IF52.7
err2025-10-09
err0
errOAAI
errHaifeng Lin; Yi Han; Lei Guo; Caigang Liu; Hefei Li; Jie Li; Chong Wang; Lijuan Zhou; Xiangna Zhang; Lisha Sun; Ying Yi Zhang; Xiaojing Chu; Jianquan Shi; Xiaoqing Cao; Yifang Chen; Zhiqing Qin; Jiaming Bao; Shiya Wan; Hao Chen; Xiaoran Tang; Xiang Li; Xinyu Wang; Yuting Cheng; Yixia Li; Jie Zhang; Chang Liu; Xuguang Zhang; Yanan Wang; Yi Hu; Nanying Che; Xiaowei Xu; Hezhe Lu
err分享
err收藏
From mechanism to application: programmed cell death pathways in nanomedicine-driven cancer therapies张, Z.; 吴, Y.; 刘, Y.; 张, J.; 张, Y.; 戴, Y.; 刘, C. 从机制到应用: 纳米医学驱动的癌症治疗中的程序性细胞死亡通路. Bioact. Mater. 2025, 52, 773–809. [Google Scholar] [CrossRef]
errBIOACTIVE MATERIALS
IF20.3
err2025-10-01
err5
errOAAI
errZhang, Zhan; Wu, Yuanzhen; Liu, Yanchen; Zhang, Jingyu; Zhang, Yan; Dai, Yunlu; Liu, Caigang
err分享
err收藏
Neoadjuvant chidamide combined with chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (MUKDEN 05): a multicentre, single-arm, phase 2 trial新辅助氯米芬联合化疗在激素受体阳性、人表皮生长因子受体2阴性乳腺癌患者中的应用（MUKDEN 05）：一项多中心、单臂、II期临床试验
errThe Lancet Regional Health - Western Pacific
IF0
err2025-09-27
err0
errOAAI
errJinqi Xue; Huilian Shan; Fang Qiu; Nan Niu; Guanglei Chen; Qianshi Xu; Xi Gu; Fei Xing; Yongqing Xu; Xinyu Zheng; Guijin He; Hong Xu; Hao Zhang; Dong Song; Ye Han; Meiyue Tang; Shuo Cao; Yang Song; Ran Zheng; Yafei Zhao; Gege Jiao; Mingxin Liu; Caigang Liu
err分享
err收藏
Association of human breast cancer CD44-/CD24- cells with delayed distant metastasis (vol 14, e109109, 2025 )人乳腺癌CD44-/CD24-细胞与延迟远处转移的关联 (vol 14, e109109, 2025)
errELIFE
IF0
err2025-09-10
err0
errOAAI
errQiao, Xinbo; Zhang, Yixiao; Sun, Lisha; Ma, Qingtian; Yang, Jie; Ai, Liping; Xue, Jinqi; Chen, Guanglei; Zhang, Hao; Ji, Ce; Gu, Xi; Lei, Haixin; Yang, Yongliang; Liu, Caigang
err分享
err收藏
Erratum to “A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44+ CD24- enriched breast cancer stem-like cells” [Drug Resist. Updates 66 (2023) 100903]勘误：“A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44+ CD24- enriched breast cancer stem-like cells” [Drug Resist. Updates 66 (2023) 100903]
errDrug Resistance Updates
IF21.7
err2025-09-04
err0
PREAI
errCaigang Liu; Yixiao Zhang; Jiujiao Gao; Qi Zhang; Lisha Sun; Qingtian Ma; Xinbo Qiao; Xinnan Li; Jinchi Liu; Jiawen Bu; Zhan Zhang; Ling Han; Dongyu Zhao; Yongliang Yang
err分享
err收藏
The expression of stem cell protein Piwil2 and piR-932 in breast cancer (vol 22, pg 217, 2013)干细胞蛋白Piwil2和piR-932在乳腺癌中的表达（vol 22, pg 217, 2013）
errSURGICAL ONCOLOGY-OXFORD
IF2.4
err2025-09-01
err0
errOAAI
errZhang, Hao; Ren, Yuan; Xu, Huanming; Pang, Deyan; Duan, Chao; Liu, Caigang
err分享
err收藏
Emerging cGAS-STING Agonist-Based Nanotherapeutics: Mechanistic Insights and Applications in Cancer Combination Therapy新兴的cGAS-STING激动剂基纳米疗法：机制洞察及其在癌症联合治疗中的应用
errAdvanced Science
IF14.1
err2025-08-21
err0
errOAAI
errZhaomeng Wang; Yongjun Wang; Zhonggui He; Caigang Liu
err分享
err收藏
ASO Visual Abstract: Surgical and Oncologic Outcomes of Tumescence and Sharp Dissection Versus Electrocautery Dissection in Minimal Access Nipple-Sparing Mastectomy with Immediate Prosthesis Breast Reconstruction: A Real-World Retrospective Cohort StudyASO视觉摘要：肿胀麻醉联合锐性分离与电刀分离在极小切口保留乳头乳房切除术联合即刻假体乳房再造术中的手术及肿瘤学结局：一项真实世界回顾性队列研究
errAnnals of Surgical Oncology
IF3.5
err2025-07-30
err0
errOAAI
errXinyu Ou; Zhihan Liu; Caigang Liu; Kun Wang; Pusheng Zhang; Xuli Meng; Wei Wei; Yuan Shi; Shu Liu; Taolang Li; Tai Xu; Wei Tang; Chenlu Liu; Jiangtao Li; Zixuan Li; Jianli Zhao; Yan Nie; GuangLei Chen; Zhenye Lv; Xiaoling Liu; Yandan Yao; Yiwen Lu; Shicheng Su
err分享
err收藏
Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer (vol 12, 142, 2014)AGBL2表达及其抑制剂Latexin在乳腺癌中的临床意义（卷12，142，2014）
errworld journal of clinical oncology
IF2.5
err2025-05-14
err0
errOAAI
errZhang, Hao; Ren, Yuan; Pang, Deyan; Liu, Caigang
err分享
err收藏
Targeting SOST using a small-molecule compound retards breast cancer bone metastasis (vol 21, 228, 2022)靶向SOST的小分子化合物延缓了乳腺癌骨转移（卷21，期228，2022）
errMOLECULAR CANCER
IF33.9
err2025-04-16
err0
errOAAI
errSun, Lisha; Zhang, Yixiao; Chen, Guanglei; Ji, Yaoting; Ma, Qingtian; Qiao, Xinbo; Wu, Sijin; Zhou, Lin; Bu, Jiawen; Zhu, Xudong; Zhang, Xiaoying; Jiang, Xiaofan; Liu, Chao; Li, Xinnan; Liu, Yang; Yang, Yongliang; Liu, Caigang
err分享
err收藏
BD-StableNet: a deep stable learning model with an automatic lesion area detection function for predicting malignancy in BI-RADS category 3-4A lesions
errPHYSICS IN MEDICINE AND BIOLOGY
IF3.4
err2024-12-03
err0
PREAI
errQu, Hui; Chen, Guanglei; Li, Tong; Zou, Mingchen; Liu, Jiaxi; Dong, Canwei; Tian, Ye; Liu, Caigang; Cui, Xiaoyu
err分享
err收藏
Efficacy and safety of JMT103 in patients with unresectable or surgically-challenging giant cell tumor of bone: a multicenter, phase Ib/II study
errNATURE COMMUNICATIONS
IF15.7
err2024-11-05
err0
errOAAI
errXu, Hairong; Zhou, Yong; Liang, Li; Shen, Jingnan; Yan, Wangjun; Wang, Jin; Li, Jianmin; Zhang, Xiaojing; Huang, Gang; Bi, Wenzhi; Guo, Zheng; Xiao, Yanbin; Lin, Jianhua; Yao, Weitao; Tong, Zhichao; Zhou, Wenxian; Zhang, Guochuan; Ye, Zhaoming; Wang, Dong; Yang, Jilong; Fan, Zhengfu; Liu, Caigang; Qu, Guofan; Zhang, Qing; Wei, Feng; Liu, Weifeng; Tu, Chongqi; Li, Hong; Yuan, Jing; Niu, Xiaohui
err分享
err收藏
Update of the INSPIRE study: Iruplinalkib versus crizotinib in ALK TKI-naive locally advanced or metastatic ALK plus non-small cell lung cancer (NSCLC)INSPIRE研究更新：Iruplinalkib与crizotinib在ALK TKI初治的局部晚期或转移性ALK阳性非小细胞肺癌（NSCLC）中的比较
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err1
PREAI
errShi, Y-K.; Chen, J.; Yang, R.; Wu, H.; Wang, Z.; Yang, W.; Cui, J.; Zhang, Y.; Liu, C.; Cheng, Y.; Liu, Y.; Shan, J.; Wang, D.; Yang, L.; Hu, C.; Si, M.; Li, H.; Li, L.; Kang, X.; Wang, L.
err分享
err收藏
Efficacy and safety of integrating consolidative thoracic radiotherapy with immunochemotherapy in ES-SCLC: A real-world retrospective analysis整合巩固性胸腔放疗与免疫化疗在ES-SCLC中的疗效与安全性：一项真实世界回顾性分析
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errZhang, Q.; Liu, C.; Wu, X.; Zheng, C.; Wang, Y.
err分享
err收藏
Comparing the Efficacy and Safety of TQB2440 versus the Reference Pertuzumab for the Treatment of HER2-Positive Early or Locally Advanced Breast Cancer: A Multicenter, Randomized, Double-Blind, Parallel-Controlled Phase 3 Trial
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errZhang, Qingyuan; Wang, Shusen; Li, Nanlin; Cheng, Qiao; Ren, Yu; Cao, Xuchen; Huang, Jianjun; Liu, Caigang; Yang, Hongwei; Wei, Limin; Song, Zhangjun; Zhao, Huadong; Ning, Fangling; Wang, Xiaojia; Zou, Dehong; Zeng, Xiaohua; Hao, Jie; Liu, Yunjiang; Wang, Huijuan; Nie Jianyun; Li, Liang; Liu, Lina; Sun, Tao; Hu, Xiaobo; Zhai, Zhenhua; Xiong, Huihua; Zhang, Yuanqi; Zhou, Enxiang; Sun, Jing; Cai, Zhenhai; Zhang, Antai; Wang, Shui; Mo, Junyang; Su, Qun; Qi, Xiuheng; Zhou, Guoren; Zhang, Shuqun; Cui, Guozhong; Wang, Wei; Fan, Mingjiang; Qian, Xinyu; Wu, Xinhong; Wang, Zhihong; Zhao, Jiuda; Luo, Yonghui; Zhang, Yanming; Tian, Fuguo; Zhang, Jiye; Chai, Dongning; Li, Qingshan
err分享
err收藏
Polyphenol nanocomplex modulates lactate metabolic reprogramming and elicits immune responses to enhance cancer therapeutic effect多酚纳米复合物调节乳酸代谢重编程并引发免疫反应以增强癌症治疗效果
errDRUG RESISTANCE UPDATES
IF21.7
err2024-03-01
err6
errOAAI
errZhang, Zhan; Li, Xinnan; Liu, Weiqiang; Chen, Guanglei; Liu, Jinchi; Ma, Qingtian; Hou, Pengjie; Liang, Lu; Liu, Caigang
err分享
err收藏
Articular Cartilage Regeneration via Induced Chondrocyte Autophagy by Sustained Release of Leptin Inhibitor from Thermo-Sensitive Hydrogel Through STAT3/REDD1/mTORC1 Cascade (vol 12, e2302181, 2023)
errADVANCED HEALTHCARE MATERIALS
IF9.6
err2024-01-26
err0
errOAAI
errHuang, Z.; Liu, C.; Zheng, G.; Zhang, L.; Zhong, Q.; Zhang, Y.; Zhao, W.; Qi, Y.
err分享
err收藏
CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer (Vol 22, 6, 2023)
errMOLECULAR CANCER
IF33.9
err2024-01-05
err0
errOAAI
errXing, Fei; Gao, Hongli; Chen, Guanglei; Sun, Lisha; Sun, Jiayi; Qiao, Xinbo; Xue, Jinqi; Liu, Caigang
err分享
err收藏
Effects of neoadjuvant stereotactic body radiotherapy plus adebrelimab and chemotherapy for triple-negative breast cancer: A pilot study新辅助立体定向放疗加adebrelimab和化疗对三阴性乳腺癌的影响: 一项初步研究
errELIFE
IF0
err2023-12-22
err5
errOAAI
errChen, Guanglei; Gu, Xi; Xue, Jinqi; Zhang, Xu; Yu, Xiaopeng; Zhang, Yu; Li, Ailin; Zhao, Yi; He, Guijin; Tang, Meiyue; Xing, Fei; Yin, Jianqiao; Bian, Xiaobo; Han, Ye; Cao, Shuo; Liu, Chao; Jiang, Xiaofan; Zhang, Keliang; Xia, Yan; Li, Huajun; Niu, Nan; Liu, Caigang
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
陈晓栋 封面图
陈晓栋 (Xiaohong Chen)
H 指数: 258 · 论文数: 1.9W
C
Carlo M. Croce
H 指数: 209 · 论文数: 1.8K
刘
刘颖 (Ying Liu)
H 指数: 118 · 论文数: 2.5K
P
Peng Chen
H 指数: 113 · 论文数: 673
朱
朱彤 (Tong Zhu)
H 指数: 103 · 论文数: 1.6K
查看更多